Murat Çetin
Research Subjects
Murat Çetin has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Serhat Karadavut
Division of Cardiology, Kayseri City Hospital, Kayseri, Turkey
2 shared publications - Ali Kaplan
Kayseri Universitesi
1 shared publication - Gülşah Akyol
Erciyes University Faculty of Medicine, Department of Hematology, Kayseri, Türkiye
1 shared publication - Ismail Altintop
Department of Emergency Medicine, Kayseri Faculty of Medicine, University of Health Sciences, 38080 Kayseri, Türkiye
1 shared publication - İlHami Celik
Infectious Diseases Clinical, University of Health Sciences, Kayseri City Training and Research Hospital, Kayseri, Türkiye
1 shared publication - Omer Sahin
Department of Cardiology, Kayseri Education and Research Hospital, Kayseri, Turkey
1 shared publication
Latest Publications
- 1 January 2024
- Published by Kare Publishing in Eurasian Journal of Medical Advances
- Vol. 4 (1) , 13-21
The Effect of Respiratory Exercises on People with Ongoing Dyspnea and Recovered from COVID-19
Objectives: Dyspnea is the most common symptom after having coronavirus disease 2019 (COVID-19). In this study, we evaluated the effect of respiratory exercises on dyspnea in the post-acute period in people who recovered from COVID-19 disease but continued to have dyspnea. Methods: This research was a randomized controlled, single-blind experimental study. Research data were collected between October 1, 2020 and January 31, 2021, and a total of 50 patients, 24 intervention and 26 control groups, were included in the study. The intervention group received diaphragmatic and lip-contraction breathing exercises for 10 minutes twice a day for a month, while the control group did not receive any exercise in addition to standard treatment. Dyspnea-12 (D-12) and the Numerical Rating Scale (NRS) were used as outcome measurement tools. Results: There was no difference between initial D-12 and NRS scores in the intervention and control groups, and the groups were normally distributed. After the application, the D-12 and NRS Scale scores of the intervention group were significantly lower than those of the control group (p<0.05). Moreover, the last measurements of the intervention group were significantly lower than the D-12and NRS scores than the initial measurements (p<0.05). Conclusion: According to the results obtained, diaphragmatic and pursed lip breathing exercises are effective on postrecovery dyspnea in COVID-19 patients.
- 1 January 2024
- Published by Kare Publishing in Eurasian Journal of Medical Advances
- Vol. 4 (1) , 13-21
The Effect of Respiratory Exercises on People with Ongoing Dyspnea and Recovered from COVID-19
Objectives: Dyspnea is the most common symptom after having coronavirus disease 2019 (COVID-19). In this study, we evaluated the effect of respiratory exercises on dyspnea in the post-acute period in people who recovered from COVID-19 disease but continued to have dyspnea. Methods: This research was a randomized controlled, single-blind experimental study. Research data were collected between October 1, 2020 and January 31, 2021, and a total of 50 patients, 24 intervention and 26 control groups, were included in the study. The intervention group received diaphragmatic and lip-contraction breathing exercises for 10 minutes twice a day for a month, while the control group did not receive any exercise in addition to standard treatment. Dyspnea-12 (D-12) and the Numerical Rating Scale (NRS) were used as outcome measurement tools. Results: There was no difference between initial D-12 and NRS scores in the intervention and control groups, and the groups were normally distributed. After the application, the D-12 and NRS Scale scores of the intervention group were significantly lower than those of the control group (p<0.05). Moreover, the last measurements of the intervention group were significantly lower than the D-12and NRS scores than the initial measurements (p<0.05). Conclusion: According to the results obtained, diaphragmatic and pursed lip breathing exercises are effective on postrecovery dyspnea in COVID-19 patients.
- 30 November 2023
- Published by Taylor & Francis in Acta Cardiologica
- Vol. 79 (3) , 344-350
The effect of COVID-19 on the thromboembolic outcomes in atrial fibrillation patients in the long run
BackgroundWhile there has been a wealth of reports concerning the acute effects of the coronavirus disease 2019 (COVID-19), further information is needed to see how things unfold in the long run. This research aimed to ascertain whether the COVID-19 pandemic has increased the probability of thromboembolic events in atrial fibrillation (AF) patients.MethodsIn this retrospective study, we scanned 952 AF patients and classified 643 eligible ones per their history of catching COVID-19. Two hundred thirty-nine of 643 patients had a history of COVID-19 (Group 1), and 404 did not (Group 2). We then compared two years of thromboembolic events between the groups.ResultsComposite thromboembolic outcomes were seen in 76 (11.8%) patients. Of those, 32 (13.4%) were in Group 1, and 44 (10.8%) were in Group 2 (p = .03). 10 of 32 patients (31%) in Group 1 and 11 of 44 (25%) in Group 2 died because of thromboembolic events (p = .02). Histories of diabetes mellitus, chronic obstructive pulmonary disease, and COVID-19 independently predicted thromboembolic events in AF patients.ConclusionsHaving caught COVID-19 is likely to be associated with increased long-term thromboembolic outcomes in AF patients. Albeit the study design does not permit us to infer causality, our results question the necessity of more intensive anticoagulant therapy and closer follow-up in AF patients with past COVID-19.
- 30 November 2023
- Published by Taylor & Francis in Acta Cardiologica
- Vol. 79 (3) , 344-350
The effect of COVID-19 on the thromboembolic outcomes in atrial fibrillation patients in the long run
BackgroundWhile there has been a wealth of reports concerning the acute effects of the coronavirus disease 2019 (COVID-19), further information is needed to see how things unfold in the long run. This research aimed to ascertain whether the COVID-19 pandemic has increased the probability of thromboembolic events in atrial fibrillation (AF) patients.MethodsIn this retrospective study, we scanned 952 AF patients and classified 643 eligible ones per their history of catching COVID-19. Two hundred thirty-nine of 643 patients had a history of COVID-19 (Group 1), and 404 did not (Group 2). We then compared two years of thromboembolic events between the groups.ResultsComposite thromboembolic outcomes were seen in 76 (11.8%) patients. Of those, 32 (13.4%) were in Group 1, and 44 (10.8%) were in Group 2 (p = .03). 10 of 32 patients (31%) in Group 1 and 11 of 44 (25%) in Group 2 died because of thromboembolic events (p = .02). Histories of diabetes mellitus, chronic obstructive pulmonary disease, and COVID-19 independently predicted thromboembolic events in AF patients.ConclusionsHaving caught COVID-19 is likely to be associated with increased long-term thromboembolic outcomes in AF patients. Albeit the study design does not permit us to infer causality, our results question the necessity of more intensive anticoagulant therapy and closer follow-up in AF patients with past COVID-19.
- Open Access
- 24 May 2022
- Published by Anadolu Klinigi Tip Bilimleri Dergisi in Anadolu Kliniği Tıp Bilimleri Dergisi
- Vol. 27 (2) , 142-149
Atriyal fibrilasyon hastalarında nabız basıncı indeksinin kardiyoembolik olaylar ve mortalite ile ilişkisi
Amaç: Nabız basınç indeksi (NBİ), nabız basıncının (NB) sistolik kan basıncına oranı ile elde edilir. Arteriyel sertlik ve kardiyovasküler hastalıkların (KVH) değerlendirilmesinde NB ölçümlerine göre daha güvenilir ve daha objektif bilgi verir. Bilindiği üzere atriyal fibrilasyonda (AF) vasküler hastalık mevcudiyeti emboli riskini artırmaktadır. Bu çalışmada, KVH prediktörü olan NBİ değerlerini kullanarak AF hastalarında gelişen kardiyoembolik olaylar (KEO) ve/veya mortalite ile ilişkisini incelemeyi amaçladık.Yöntemler: Çalışma, Şubat 2019 ile Haziran 2020 arasında prospektif olarak 191 AF hastası alınarak yapıldı. Hastalar; inme, geçici iskemik atak, periferik emboli ve bunlara bağlı ölüm gerçekleşmeyen (Grup-1, n=156) ve gerçekleşen (Grup-2, n=35) şeklinde ikiye ayrıldı. Bulgular: Grup-2’nin NBİ değerleri Grup-1’e göre anlamlı derecede yüksek olarak tespit edildi (0,38±0,05 ve 0,41±0,04, p<0,001). Çoklu regresyon analizi sonrası NBİ AF hastalarında KEOaçısından bağımsız öngörücü olarak bulundu (Olasılık oranı: 2,82 [%95 Güven Aralığı: 1,68-4,71], p<0,001). Ayrıca, yapılan ROC analizinde NBİ, NB’ye göre KEO tahmin etmede daha güçlü bir parametre olarak saptandı (sırasıyla, eğri altındaki alan [AUC]=0,734 ve AUC=0,661).Sonuç: AF hastalarında NBİ istenmeyen KEO ve buna bağlı ölümleri predikte etmek için kullanılabilecek non-invaziv ve ucuz bir fizik muayene bulgusudur.
- 24 May 2022
- Published by Anadolu Klinigi Tip Bilimleri Dergisi in Anadolu Kliniği Tıp Bilimleri Dergisi
- Vol. 27 (2) , 142-149
Open AccessAtriyal fibrilasyon hastalarında nabız basıncı indeksinin kardiyoembolik olaylar ve mortalite ile ilişkisi
Amaç: Nabız basınç indeksi (NBİ), nabız basıncının (NB) sistolik kan basıncına oranı ile elde edilir. Arteriyel sertlik ve kardiyovasküler hastalıkların (KVH) değerlendirilmesinde NB ölçümlerine göre daha güvenilir ve daha objektif bilgi verir. Bilindiği üzere atriyal fibrilasyonda (AF) vasküler hastalık mevcudiyeti emboli riskini artırmaktadır. Bu çalışmada, KVH prediktörü olan NBİ değerlerini kullanarak AF hastalarında gelişen kardiyoembolik olaylar (KEO) ve/veya mortalite ile ilişkisini incelemeyi amaçladık.Yöntemler: Çalışma, Şubat 2019 ile Haziran 2020 arasında prospektif olarak 191 AF hastası alınarak yapıldı. Hastalar; inme, geçici iskemik atak, periferik emboli ve bunlara bağlı ölüm gerçekleşmeyen (Grup-1, n=156) ve gerçekleşen (Grup-2, n=35) şeklinde ikiye ayrıldı. Bulgular: Grup-2’nin NBİ değerleri Grup-1’e göre anlamlı derecede yüksek olarak tespit edildi (0,38±0,05 ve 0,41±0,04, p<0,001). Çoklu regresyon analizi sonrası NBİ AF hastalarında KEOaçısından bağımsız öngörücü olarak bulundu (Olasılık oranı: 2,82 [%95 Güven Aralığı: 1,68-4,71], p<0,001). Ayrıca, yapılan ROC analizinde NBİ, NB’ye göre KEO tahmin etmede daha güçlü bir parametre olarak saptandı (sırasıyla, eğri altındaki alan [AUC]=0,734 ve AUC=0,661).Sonuç: AF hastalarında NBİ istenmeyen KEO ve buna bağlı ölümleri predikte etmek için kullanılabilecek non-invaziv ve ucuz bir fizik muayene bulgusudur.
- Open Access
- 3 May 2019
- Published by Galenos Yayinevi in Turkish Journal of Hematology
- Vol. 36 (2) , 135-137
A Successful Coronary Artery Bypass Operation with Intermittent Factor VIII Administration in a Hemophilia A Patient Who Was Admitted Due to Acute Myocardial Infarction: A Rare and Difficult Case
- 3 May 2019
- Published by Galenos Yayinevi in Turkish Journal of Hematology
- Vol. 36 (2) , 135-137
Open AccessA Successful Coronary Artery Bypass Operation with Intermittent Factor VIII Administration in a Hemophilia A Patient Who Was Admitted Due to Acute Myocardial Infarction: A Rare and Difficult Case